Sandler Center for Drug Discovery, California Institute for Quantitative Biosciences (QB3), University of California San Francisco, San Francisco, California, United States of America.
PLoS Negl Trop Dis. 2010 Oct 19;4(10):e850. doi: 10.1371/journal.pntd.0000850.
The possible emergence of resistance to the only available drug for schistosomiasis spurs drug discovery that has been recently incentivized by the availability of improved transcriptome and genome sequence information. Transient RNAi has emerged as a straightforward and important technique to interrogate that information through decreased or loss of gene function and identify potential drug targets. To date, RNAi studies in schistosome stages infecting humans have focused on single (or up to 3) genes of interest. Therefore, in the context of standardizing larger RNAi screens, data are limited on the extent of possible off-targeting effects, gene-to-gene variability in RNAi efficiency and the operational capabilities and limits of RNAi.
METHODOLOGY/PRINCIPAL FINDINGS: We investigated in vitro the sensitivity and selectivity of RNAi using double-stranded (ds)RNA (approximately 500 bp) designed to target 11 Schistosoma mansoni genes that are expressed in different tissues; the gut, tegument and otherwise. Among the genes investigated were 5 that had been previously predicted to be essential for parasite survival. We employed mechanically transformed schistosomula that are relevant to parasitism in humans, amenable to screen automation and easier to obtain in greater numbers than adult parasites. The operational parameters investigated included defined culture media for optimal parasite maintenance, transfection strategy, time- and dose-dependency of RNAi, and dosing limits. Of 7 defined culture media tested, Basch Medium 169 was optimal for parasite maintenance. RNAi was best achieved by co-incubating parasites and dsRNA (standardized to 30 µg/ml for 6 days); electroporation provided no added benefit. RNAi, including interference of more than one transcript, was selective to the gene target(s) within the pools of transcripts representative of each tissue. Concentrations of dsRNA above 90 µg/ml were directly toxic. RNAi efficiency was transcript-dependent (from 40 to >75% knockdown relative to controls) and this may have contributed to the lack of obvious phenotypes observed, even after prolonged incubations of 3 weeks. Within minutes of their mechanical preparation from cercariae, schistosomula accumulated fluorescent macromolecules in the gut indicating that the gut is an important route through which RNAi is expedited in the developing parasite.
Transient RNAi operates gene-selectively in S. mansoni newly transformed schistosomula yet the sensitivity of individual gene targets varies. These findings and the operational parameters defined will facilitate larger RNAi screens.
唯一可用的血吸虫病药物可能出现耐药性,这促使人们开展药物研发,而转录组和基因组序列信息的可用性最近为此提供了激励。瞬时 RNAi 已成为一种直接而重要的技术,可以通过降低或丧失基因功能来研究这些信息,并确定潜在的药物靶点。迄今为止,针对感染人类的血吸虫阶段的 RNAi 研究主要集中在少数(或最多 3 个)感兴趣的基因上。因此,在标准化更大规模的 RNAi 筛选的背景下,关于可能的脱靶效应的程度、RNAi 效率的基因间变异性以及 RNAi 的操作能力和限制的数据有限。
方法/主要发现:我们使用双链 RNA(dsRNA)(约 500bp)研究了体外 RNAi 的敏感性和选择性,该 dsRNA 设计用于靶向 11 种曼氏血吸虫表达于不同组织(肠道、表皮和其他组织)的基因;其中 5 种基因先前被预测为寄生虫生存所必需。我们使用了与人类寄生虫病相关的机械转化的尾蚴,这些尾蚴适用于筛选自动化,并且比成虫更容易获得更多数量。研究的操作参数包括用于最佳寄生虫维持的定义培养基、转染策略、RNAi 的时间和剂量依赖性以及剂量限制。在测试的 7 种定义培养基中,巴奇培养基 169 是维持寄生虫的最佳培养基。通过将寄生虫和 dsRNA 共孵育(标准化为 30µg/ml 持续 6 天)可实现最佳 RNAi;电穿孔没有提供额外的益处。RNAi 包括对多个转录本的干扰,对每种组织代表的转录本池中的基因靶标具有选择性。高于 90µg/ml 的 dsRNA 浓度具有直接毒性。RNAi 效率依赖于转录本(相对于对照, knockdown 率为 40%至>75%),这可能导致即使在长达 3 周的孵育后也观察不到明显的表型。从尾蚴机械制备后的几分钟内,尾蚴就在肠道中积累了荧光大分子,这表明肠道是 RNAi 在发育中的寄生虫中加速的重要途径。
瞬时 RNAi 在新转化的曼氏血吸虫尾蚴中选择性地作用于基因,但个别基因靶标的敏感性不同。这些发现和定义的操作参数将有助于更大规模的 RNAi 筛选。